Skip to main content
logo
Enimmune Corporation (TPEX:6564)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.50
+0.40 (2.48%)
Aug 26, 2026, 1:47 PM CST

Enimmune Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
53.4548.1939.9243.49188.42109.82
Revenue Growth
10.90%20.74%-8.23%-76.92%71.56%380.07%
Gross Profit
4.318.0214.23-23.3720.8438.72
Operating Income
-124.27-185.24-151.14-243.48-286.42-58.67
Net Income
-120.88-164.35-157.55-223.74-247.96-47.25
Earnings Per Share
-1.68-2.28-2.20-3.40-3.88-0.79
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
172.45225.79489.81364.79487.07349.79
Total Debt
159.57171.19107.845.7329.668.08
Net Cash (Debt)
12.8854.59382319.06457.41341.7
Net Cash Growth
-76.42%-85.71%19.73%-30.25%33.86%-17.02%
Net Cash Per Share
0.180.765.344.857.165.70

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-83.45-143.25-143.78-138.13-200.64-71.55
Capital Expenditures
-2.75-4.18-0.47--0.35-2.98
Free Cash Flow
-86.19-147.43-144.25-138.13-200.98-74.53
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
8.06%16.63%35.64%-53.74%11.06%35.26%
Operating Margin
-232.49%-384.36%-378.66%-559.79%-152.01%-53.42%
Pretax Margin
-226.16%-341.41%-414.81%-546.49%-141.75%-43.02%
Profit Margin
-226.16%-341.01%-394.70%-514.42%-131.60%-43.02%
FCF Margin
-161.26%-305.91%-361.39%-317.59%-106.67%-67.86%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.7330.8345.0056.7321.3421.55